A critical overview of computational approaches employed for COVID-19 drug discovery

Author:

Muratov Eugene N.1,Amaro Rommie2ORCID,Andrade Carolina H.3,Brown Nathan4ORCID,Ekins Sean5,Fourches Denis6,Isayev Olexandr7,Kozakov Dima8,Medina-Franco José L.9ORCID,Merz Kenneth M.10,Oprea Tudor I.111213ORCID,Poroikov Vladimir14ORCID,Schneider Gisbert15ORCID,Todd Matthew H.16ORCID,Varnek Alexandre1718,Winkler David A.192021ORCID,Zakharov Alexey V.22,Cherkasov Artem23ORCID,Tropsha Alexander1ORCID

Affiliation:

1. UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA

2. University of California in San Diego, San Diego, CA, USA

3. Department of Pharmacy, Federal University of Goias, Goiania, GO, Brazil

4. BenevolentAI, London, UK

5. Collaborations Pharmaceuticals, Raleigh, NC, USA

6. Department of Chemistry, North Carolina State University, Raleigh, NC, USA

7. Department of Chemistry, Carnegie Melon University, Pittsburgh, PA, USA

8. Department of Applied Mathematics and Statistics, Stony Brook University, Stony Brook, NY, USA

9. Department of Pharmacy, National Autonomous University of Mexico, Mexico City, DF, Mexico

10. Department of Chemistry, Michigan State University, East Lansing, MI, USA

11. Department of Internal Medicine and UNM Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM, USA

12. Department of Rheumatology and Inflammation Research, Gothenburg University, Sweden

13. Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Denmark

14. Institute of Biomedical Chemistry, Moscow, Russia

15. Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, Zurich, Switzerland

16. School of Pharmacy, University College of London, London, UK

17. Department of Chemistry, University of Strasbourg, Strasbourg, France

18. Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Japan

19. Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia

20. School of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Australia

21. School of Pharmacy, University of Nottingham, Nottingham, UK

22. National Center for Advancing Translational Science, Bethesda, MD, USA

23. Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada

Abstract

We cover diverse methodologies, computational approaches, and case studies illustrating the ongoing efforts to develop viable drug candidates for treatment of COVID-19.

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

National Institutes of Health

Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México

National Science Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Cited by 129 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3